Search results

Det är mycket på gång inom Svensk Fågeltaxering nu då vinter och vår möts. Vinterns sista punktruttsräkningar görs i dagarna och nattrutterna är i full gång. Det återstår åtta dagar att göra period 5 på vinterpunktrutterna. En viktig räkning där vi även får goda data på de fåglar som börjar sjunga och hävda revir tidigt på våren, så som mesar och hackspettar. Sista dag för period 5 är 21 mars. Sam

https://www.fageltaxering.lu.se/artikel/nu-mots-vinter-och-var-1 - 2025-11-23

Bokningen av standardrutterna för våren och försommaren 2025 är igång. Dags för trettionde säsongen! Standardrutterna startade 1996 med målet att täcka hela Sverige och dess olika naturtyper på ett representativt sätt. På så sätt får vi också bästa möjliga bild av hur den svenska fågelfaunan förändras. Nu är det dags igen, för trettionde året i rad. En standardrutt bokas av oss i förväg. De som gj

https://www.fageltaxering.lu.se/artikel/boka-en-standardrutt - 2025-11-23

Årsrapporten för 2024 är tryckt och vår hemsida är uppdaterad med nya trender och indikatorer Årsrapporten för 2024 är nu tryckt. Som vanligt innehåller den uppdaterade trender för mer än 200 svenska fågelarter, 13 däggdjursarter och fem groddjursarter, samt våra tre fågelbaserade miljömålsindikatorer. Rapporten är skickad i pappersform till de som efterfrågat sådan, alla andra inventerare har fåt

https://www.fageltaxering.lu.se/artikel/ny-arsrapport-och-hemsidan-uppdaterad - 2025-11-23

Perioden 2002-2022 är det lika många arter som ökat som minskat i svenska fjällen. Samtidigt blev det relativt sett fler individer av mer värmeälskande (sydliga) arter. I en ny rapport visas utvecklingen för häckande fåglar i svenska fjällen under perioden 2002–2022, som den registrerats inom det för länsstyrelserna gemensamma delprogrammet "Häckande fåglar i fjällen". Data kommer från sammanlagt

https://www.fageltaxering.lu.se/artikel/allt-fler-sydliga-faglar-i-fjallen-ny-rapport-ute - 2025-11-23

Sveriges ornitologer har med hjälp av så kallade punktrutter inventerat fåglar på vintern i Sverige sedan 1975. Dessa räkningar är speciellt viktiga då vi med deras hjälp kan följa hur klimatförändringarna påverkar antalet övervintrande fåglar. Nu drar säsong 51 igång! Vinterpunktrutternas (Vinterfågelräkningen) första inventeringsperiod inleds söndag 5 oktober. På vinterpunktrutterna räknar vi få

https://www.fageltaxering.lu.se/artikel/dags-vinterpunktrutterna-0 - 2025-11-23

This year, MultiPark has the pleasure of welcoming two new research groups. The Mackenzie Lab aims to decode the neurobiological underpinnings of emotion through experimental studies in animal models. Jacob Vogel’s team uses AI to analyze clinical data for improved understanding as well as patient-tailored diagnosis and care of neurodegenerative disease patients. Say hello to Åsa Mackenzie and Jac

https://www.multipark.lu.se/article/multipark-grows-new-research-groups - 2025-11-23

What role does an inflammatory protein have in disease development? Which neuronal circuits cause different symptoms? How may diabetes affect Parkinson’s disease? Can motor signs be identifies early in individuals at risk for the disease? And how should patients in very advanced disease stages be treated to maintain their quality of life? These questions may soon have answers thanks to several ong

https://www.multipark.lu.se/article/molecule-patient-six-promising-projects-advance-parkinsons-research - 2025-11-23

Researchers at Lund University and Washington University have identified a blood marker that reflects the amount of Alzheimer’s pathology in the brain. This discovery may play a key role in determining who is most likely to benefit from the new Alzheimer’s drugs. In brief:A newly discovered blood marker, MTBR-tau243, can reveal how much Alzheimer’s disease pathology is present in the brain. The hi

https://www.multipark.lu.se/article/new-reliable-blood-marker-reveals-extent-alzheimers-pathology-brain - 2025-11-23

A simpler method of analysing blood samples for Alzheimer’s disease has been tested in a large multicentre study, led by Lund University in Sweden. “This is a major step in bringing simple blood tests for Alzheimer’s disease into the healthcare system globally,” say the researchers behind the study. In brief:The blood-based marker (P-tau217) may start to change several years before the onset of Al

https://www.multipark.lu.se/article/more-opportunities-test-alzheimers-using-new-analytical-method - 2025-11-23

Meet our scientist Gesine Paul-Visse to learn what happens at the interface where the brain and the body meet: the blood-brain barrier. Here, a very specialized cell, the pericyte, protects the brain and responds strongly to disease. Gesine Paul-Visse leads Translational Neurology, one of MultiPark’s research groups. As both a neurologist and a researcher, she has focused on neurodegeneration for

https://www.multipark.lu.se/article/meet-our-scientists-podcast-gesine-paul-visse-about-brains-frontline - 2025-11-23

Researchers at MultiPark have uncovered in mice how the protein TDP-43, known for its role in several neurodegenerative diseases, disrupts the hypothalamus, the brain’s key center for metabolic control. Their study sheds new light on the role of TDP-43 in metabolic and psychiatric symptoms shared across frontotemporal dementia, Huntington’s disease, and ALS – findings that could support the develo

https://www.multipark.lu.se/article/protein-mismanagement-brains-control-center-fuels-early-symptoms-neurodegenerative-diseases - 2025-11-23

An experimental study from Lund University reveals for the first time that different Parkinson’s medications affect brain activity in distinct ways. This could explain why some patients develop impulsive and compulsive behaviors as a result of their treatment. The findings have been published in NPJ Parkinson’s Disease. Upon receiving treatment for their motor symptoms, many patients with Parkinso

https://www.multipark.lu.se/article/brain-activation-pattern-behind-impulsivity-parkinsons-treatment-discovered - 2025-11-23

Meet our scientist, Dr. Niklas Mattsson-Carlgren! He explains why studying biomarkers is essential to advancing Alzheimer’s research. Niklas Mattsson-Carlgren is part of the Clinical Memory Research group, a leading centre in the development and evaluation of novel biomarkers for Alzheimer’s disease. In this podcast episode, he discusses why biomarker research is key not only to detecting but also

https://www.multipark.lu.se/article/meet-our-scientists-podcast-niklas-mattsson-carlgren-about-biomarkers-and-future-alzheimers - 2025-11-23

With over 15 research groups dedicated to Alzheimer’s disease research, MultiPark’s goal is to understand the origins of the disease, develop early diagnostics, and improve treatments. The multidisciplinary approach sheds light on the disease from several angles, bridging basic research with clinical investigations. Here are five projects. September is World Alzheimer’s Month. Globally, around 40

https://www.multipark.lu.se/article/alzheimers-awareness-five-research-projects-shaping-future-understanding-diagnosis-and-care - 2025-11-23

For decades, large stretches of human DNA were dismissed as ‘junk’ and considered to serve no real purpose. In a new study in Cell Genomics, researchers at Lund University in Sweden show that the repetitive part of the human genome plays an active role during early brain development and may also be relevant for understanding brain diseases. DNA carries the complete set of instructions an organism

https://www.multipark.lu.se/article/why-repetitive-dna-matters-human-brain-evolution-and-disease - 2025-11-23

Enormous amounts of data about Alzheimer’s Disease have been generated from clinical studies so far. Still, the molecular drivers of Alzheimer’s Disease are largely unknown. With the TAU-TIME project, Jacob Vogel aims to advance knowledge by developing an AI tool that brings together known biological mechanisms with data from patients with the disease. Recent funding from the European Research Cou

https://www.multipark.lu.se/article/time-unite-lab-and-clinic-15-million-eu-build-ai-model-alzheimers-disease - 2025-11-23

Early diagnosis is key to receiving proper care and advancing research on future therapies for neurodegenerative diseases such as Parkinson’s and dementia with Lewy bodies. New research from Skåne University Hospital and Lund University shows that combining a simple smell test with advanced spinal fluid analysis can predict these diseases with high accuracy, while sparing nearly half of patients f

https://www.multipark.lu.se/article/smell-test-cuts-need-invasive-parkinsons-screening - 2025-11-23

Researchers at Lund University in Sweden have developed a digital cognitive test for diagnosing Alzheimer's disease that is intended for use in primary care. “This digital test, which patients perform on their own with minimal involvement from healthcare personnel, improves the primary care physician's ability to determine who should be further examined by blood tests for Alzheimer's pathology ear

https://www.multipark.lu.se/article/new-digital-cognitive-test-diagnosing-alzheimers-disease - 2025-11-23

What if brain diseases could be cured by turning on the proper genes? Meet our scientist, Professor Cecilia Lundberg! She explains how gene therapy may complement cell therapies to combat Parkinson’s disease. Cecilia Lundberg is head of the CNS Gene Therapy Research Group and has spent her whole career developing cutting-edge tools that may be used in future therapies to slow down or cure neurodeg

https://www.multipark.lu.se/article/meet-our-scientists-podcast-cecilia-lundberg-about-gene-workshop - 2025-11-23

Have you ever wondered what the journey of someone living with Parkinson’s disease looks like? Meet our scientist, Professor Per Odin! He shares his experiences of the bumpy road faced by patients he has supported over the years, both in healthcare and in research studies. Parkinson’s disease is a long, challenging course; one that science works tirelessly to understand, where halting neurodegener

https://www.multipark.lu.se/article/meet-our-scientists-podcast-odin-about-parkinsons-journey - 2025-11-23